UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intranasal delivery of antituberculosis agents in a murine tuberculosis model

International journal of infectious diseases, 2016-04, Vol.45, p.391-392

2016

Volltextzugriff (PDF)

Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model

Antimicrobial agents and chemotherapy, 1999-05, Vol.43 (5), p.1189-1191

1999

Volltextzugriff (PDF)

Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment

Antimicrobial agents and chemotherapy, 2017-06, Vol.61 (6)

2017

Volltextzugriff (PDF)

In Vitro and In Vivo Activities of Gatifloxacin against Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy, 2002-04, Vol.46 (4), p.1022-1025

2002

Volltextzugriff (PDF)

Comparative in vitro activities of TR-1710 and moxifloxacin against Mycobacterium kansasii

International journal of infectious diseases, 2014-04, Vol.21 (S1), p.199-200

2014

Volltextzugriff (PDF)

Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis

Journal of antimicrobial chemotherapy, 2008-10, Vol.62 (4), p.713-719

2008

Volltextzugriff (PDF)

Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base

Journal of antimicrobial chemotherapy, 2004-02, Vol.53 (2), p.185-191

2004

Volltextzugriff (PDF)

Prevalence and risk factors for drug resistance among hospitalized tuberculosis patients in Georgia

The international journal of tuberculosis and lung disease, 2009-09, Vol.13 (9), p.1148

2009

Volltextzugriff (PDF)

Iron-cofactored Superoxide Dismutase Inhibits Host Responses to Mycobacterium tuberculosis

American journal of respiratory and critical care medicine, 2001-12, Vol.164 (12), p.2213-2219

2001

Volltextzugriff (PDF)

Gatifloxacin and Ethionamide as the Foundation for Therapy of Tuberculosis

Antimicrobial Agents and Chemotherapy, 2003-08, Vol.47 (8), p.2442-2444

2003

Volltextzugriff (PDF)

Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy, 1997-03, Vol.41 (3), p.540-543

1997

Volltextzugriff (PDF)

High-Dose Isoniazid Therapy for Isoniazid-Resistant Murine Mycobacterium tuberculosis Infection

Antimicrobial Agents and Chemotherapy, 1999-12, Vol.43 (12), p.2922-2924

1999

Volltextzugriff (PDF)

Identification of a Novel Oxazolidinone (U-100480) with Potent Antimycobacterial Activity

Journal of medicinal chemistry, 1996-02, Vol.39 (3), p.680-685

1996

Volltextzugriff (PDF)

In Vitro Antimycobacterial Activity of 5-Chloropyrazinamide

Antimicrobial Agents and Chemotherapy, 1998-02, Vol.42 (2), p.462-463

1998

Volltextzugriff (PDF)

Comparative In vitro Activities of Several Oxazolidinones against Mycobacterium kansasii

International journal of infectious diseases, 2018-08, Vol.73, p.346-346

2018

Volltextzugriff (PDF)

Attenuation of Mycobacterium tuberculosis by Disruption of a mas-Like Gene or a Chalcone Synthase-Like Gene, Which Causes Deficiency in Dimycocerosyl Phthiocerol Synthesis

Journal of Bacteriology, 2003-05, Vol.185 (10), p.2999-3008

2003

Volltextzugriff (PDF)

Activity of ABT-773 against Mycobacterium avium Complex in the Beige Mouse Model

Antimicrobial Agents and Chemotherapy, 2000-10, Vol.44 (10), p.2895-2896

2000

Volltextzugriff (PDF)

The Largest Open Reading Frame (pks12) in the Mycobacterium tuberculosis Genome Is Involved in Pathogenesis and Dimycocerosyl Phthiocerol Synthesis

Infection and Immunity, 2003-07, Vol.71 (7), p.3794-3801

2003

Volltextzugriff (PDF)

BB-3497, a peptide deformylase inhibitor, is active against Mycobacterium tuberculosis

Journal of antimicrobial chemotherapy, 2004-02, Vol.53 (2), p.403-405

2004

Volltextzugriff (PDF)

Quantitative Structure−Activity Relationships for the in Vitro Antimycobacterial Activity of Pyrazinoic Acid Esters

Journal of medicinal chemistry, 1996-08, Vol.39 (17), p.3394-3400

1996

Volltextzugriff (PDF)

Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide

Antimicrobial Agents and Chemotherapy, 1995-06, Vol.39 (6), p.1269-1271

1995

Volltextzugriff (PDF)

Evaluation of Rifalazil in a Combination Treatment Regimen as an Alternative to Isoniazid-Rifampin Therapy in a Mouse Tuberculosis Model

Antimicrobial Agents and Chemotherapy, 2000-11, Vol.44 (11), p.3167-3168

2000

Volltextzugriff (PDF)

Activity of clarithromycin alone and in combination in a murine model of Mycobacterium kansasii infection

Journal of antimicrobial chemotherapy, 2003-08, Vol.52 (2), p.306-307

2003

Volltextzugriff (PDF)

Biochemical Function of msl5 (pks8 plus pks17) in Mycobacterium tuberculosis H37Rv: Biosynthesis of Monomethyl Branched Unsaturated Fatty Acids

Journal of Bacteriology, 2003-08, Vol.185 (15), p.4620-4625

2003

Volltextzugriff (PDF)

Activity of KRM-1648 in combination with isoniazid against Mycobacterium tuberculosis in a murine model

Antimicrobial Agents and Chemotherapy, 1996-02, Vol.40 (2), p.298-301

1996

Volltextzugriff (PDF)

1 – 25 von 278

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(254)
Mit Volltextzugriff
(198)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(144)
Life Sciences & Biomedicine
(141)
Humans
(119)
Biological And Medical Sciences
(99)
Medical Sciences
(96)
Female
(75)
Male
(63)
Microbiology
(57)
Pharmacology. Drug Treatments
(52)
Pharmacology & Pharmacy
(49)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(47)
Animals
(44)
Antibacterial Agents
(41)
Microbial Sensitivity Tests
(39)
Mice
(38)
Middle Aged
(36)
Aged
(34)
Adult
(33)
Cardiovascular System & Cardiology
(28)
Mycobacterium Tuberculosis
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Intranasal delivery of antituberculosis agents in a murine tuberculosis model

Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model

Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment

In Vitro and In Vivo Activities of Gatifloxacin against Mycobacterium tuberculosis

Comparative in vitro activities of TR-1710 and moxifloxacin against Mycobacterium kansasii

Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis

Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base

Prevalence and risk factors for drug resistance among hospitalized tuberculosis patients in Georgia

Iron-cofactored Superoxide Dismutase Inhibits Host Responses to Mycobacterium tuberculosis

Gatifloxacin and Ethionamide as the Foundation for Therapy of Tuberculosis

Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis

High-Dose Isoniazid Therapy for Isoniazid-Resistant Murine Mycobacterium tuberculosis Infection

Identification of a Novel Oxazolidinone (U-100480) with Potent Antimycobacterial Activity

In Vitro Antimycobacterial Activity of 5-Chloropyrazinamide

Comparative In vitro Activities of Several Oxazolidinones against Mycobacterium kansasii

Attenuation of Mycobacterium tuberculosis by Disruption of a mas-Like Gene or a Chalcone Synthase-Like Gene, Which Causes Deficiency in Dimycocerosyl Phthiocerol Synthesis

Activity of ABT-773 against Mycobacterium avium Complex in the Beige Mouse Model

The Largest Open Reading Frame (pks12) in the Mycobacterium tuberculosis Genome Is Involved in Pathogenesis and Dimycocerosyl Phthiocerol Synthesis

BB-3497, a peptide deformylase inhibitor, is active against Mycobacterium tuberculosis

Quantitative Structure−Activity Relationships for the in Vitro Antimycobacterial Activity of Pyrazinoic Acid Esters

Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide

Evaluation of Rifalazil in a Combination Treatment Regimen as an Alternative to Isoniazid-Rifampin Therapy in a Mouse Tuberculosis Model

Activity of clarithromycin alone and in combination in a murine model of Mycobacterium kansasii infection

Biochemical Function of msl5 (pks8 plus pks17) in Mycobacterium tuberculosis H37Rv: Biosynthesis of Monomethyl Branched Unsaturated Fatty Acids

Activity of KRM-1648 in combination with isoniazid against Mycobacterium tuberculosis in a murine model

Suchergebnisse filtern